Nasal Flashcards

1
Q

Fujiwara et al. Efficacy of hypofractionated RT for nasal tumors in 38 dogs

Clinical sign improvement?

Acute complications?

Late complications in dogs that survived 6 months or longer?

Median PFI and MST?

What was negatively correlated with survival?

A

30/36 dogs (83%)

28/36 (77.8%)

17/30 dogs (57%)

245 days (8 mo)

Age, breed, presence of dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tan-coleman et al. Prospective evaluation of a 5 x 4Gy prescription for palliation of canine nasal tumors

18 dogs with nasal tumors

Complete resolution of clinical signs?

Partial resolution of CS?

Median response duration?

6 dogs received second course - responded for median time?

A

78%

16.5%

178 days (6 mo)

129.5 days (4.3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mason et al. Late presentation of canine nasal tumors in UK referral hospital and treatment outcomes

Dogs in the UK presented with ___ tumors than in USA and Japan

____ from initial presentation to referral did not correlate with tumor stage at diagnosis

A

Late stage

Length of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Gieger et al. Reirradiation of canine nasal carcinomas treated with coarsely fractionated radiation protocols

37 dogs

All dogs clinically responsed and 11 had complete resolution of signs for median ____

Retreated at relapse and ___ had clinical responses

Side effects mild - 4 dogs chronic ocular discharge, and 1 enucleation

MST from first dose of RT 453 days (15 mo) and 180 days (6 mo) from second course of RT

A

114 days

70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sones et al. 2012 Survival times for canine intranasal sarcomas treated with radiation therapy: 86 cases

Overall MST?

MST for chondrosarcoma? FSA? OSA? undifferentiated sarcoma

MST for daily fractionated protocol, (MWF) fractionated protocol, palliative protocol?

Significant difference was found in?

A

444 days (15 mo)

463 days (15 mo), 379 days, 624 days (20 mo), 344 (11.5 mo)

641 (21 mo), 347 (11.5 mo), 305 (10 mo)

Dogs receiving curative intent RT vs. palliative RT

Dogs receicinv daily fractionated RT vs. MWF fractionated protocol

Use curative intent RT for intranasal sarcomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Jarrett et al. Curettage and diathermy: a treatment for feline nasal planum actinic dysplasia and superfical SCC

34 cats with actinic dysplasia and superfical SCC involving <50% of nasal planume tx with 3 cycles of currettage and diathermy procedure

Lesions ranged from actinic keratoses to invasive SCC

Median follow up time was 18.2 mo

2 cats had clinical recurrence at 161 and 192 days

Median time to recurrence was not reached

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Marcello et al. Detection of comorbidities and synchronous primary tumors via thoracic radiography and abdomnal ultrasonography and their influence on treatment outcomes in dogs with STS, primary brain tumors, and intranasal tumors

101 dogs

Abnormalities noted in how many? 27% further investigated with FNA cytology or biopsy

____% of detected abnormalities were serious comobidities and __% were primary neoplasms

A

97%

9% and 3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bowles et al. Outcome of definitive fractionated radiation followed by exenteration of the nasal cavity in dogs with sinonasal neoplasia: 16 cases

MST?

No long term side effects

A

457 days (15 mo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glasser et al. 2014 Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors

3 consecutive day, 8-12 Gy fractions of image-guided robotic SBRT

MST?

Acute side effects?

Late side effects?

A

399 days (13.3 mo)

Rare and mild

1-oronasal fistula, 6-seizures (3 dogs seizures were presenting complaint and in other 3 either progression of late side effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Harris et al. Diagnostic accuracy of 3 biopsy techniques in 117 dogs with intra-nasal neoplasia

Nasal biopsy collection methods - advanced imaging guided, rhinoscopy guided and blind biopsy

A

NO significant difference in the 3 methods

Blind biopsy may be as diagnostic as rhinoscopy guided biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Plickert et al. Characteristics of canine nasal dishcarge related to intranasal diseases: a retrospective study of 105 cases

Non-specific rhinitis (42), nasal neoplasia (23), FB (21), nasal mycosis (7), miscellaneous disorders (13)

Dogs with FB or nasal mycosis were?

Mucous component of discharge occured more often in? Hemorrhagic component?

Pure or mixed hemorrhagic discharge was significantly more common with?

Purulent component associated with longer duration of discharge and seen in ___ and ___

Dogs with FB were presented ___ and ___ more frquent

Nasal stridor more often with?

A

Significantly younger

Non-specific rhinitis and nasal neoplasia, nasal neoplasia lated >14 days

Nasal neoplasia, FB, nasal mycosis

non-specific rhinitis and FB

Earlier, sneezing

Nasal neoplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fujiwara-Igarashi et al. 2014. Evaluation of outcomes and radiation complications in 65 cats with nasal tumors treated with palliative hypofractionated RT

Clinical signs improved in?

Acute complication observed in?

Most common late complication?

Median OS and PFS

Difference between nasal LSA and other tumors?

A
  1. 2%
  2. 5%

Cataract (20%)

432 days (14.4 mo) and 229 days (7.6 mo)

None observed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Canceda et al. 2015. Combination of RT and firocoxib for the treatment of canine nasal carcinoma

Dogs with nasal carcinoma

Group 1 - firocoxib and Palliative RT

Group 2 - RT and placebo

Median PFI and OS in group 1?

Median PFI and OS in group 2?

Quality of life significantly improved in?

A

228 days (7.6 mon) and 335 days (11.2 mo)

234 (8 mo) and 244 days (8 mo) - not statistically significant

Group 1 - activity and appetite

Firocoxib and RT improved quality of life of dogs with nasal carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Finck et al. 2015. CT or rhinoscopy as the first-line procedure for suspected nasal tumor: a pilot study

12 CT, 14 rhinoscopy and 4 both

How many CT resulted in conclusion?

Rhinoscopy?

A

94%

64%

CT more reliable than rhinicopy for detecting nasal tumors and should be first line procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Haar et al. Combined rostolateral rhinotomy for removal of rostral nasal septum SCC: long term outcome in 10 dogs

Vestibutotomy facilitated full-thickenss resection of the nasal septum and tumor mass in 10 dogs and nasal floor resection in 4 dogs

No major complications and good cosmetic outcome

Tumor removal complete in 8 dogs and incomplete in 2 dogs

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Maruo. et al. 2015. Intraoperative acridine orange photodynamic therapy and cribiform electron-beam irradiation for canine intranasl tumors: a pilot study

Marginal tumor resection in combination with intraoprative AO PDT and 1 fraction of 5 Gy irradiation for canine intranasal tumors

6 dogs - 2 stage I, 1 stage II, and 3 stage IV

Median DFST and OS?

Recurrence noted in 2/6 dogs at?

AEs?

A

8.5 mo and 13 mo

4 and 7 months

Mild

Combination AO therapy may increase tumor control time in dogs with marginally resectable intranasal malignant tumors

17
Q

George et al. Outcome of dogs with intranasal lymphoma treated with various RT and chemotherapy protocols: 24 cases

Overall MST for intermediate to high grade group

MST for RT +/- chemotherapy

Chemotherapy alone

MST low grade group

A

375 days

455 days (15 months)

157 days (5 months)

823 days (27 months)

18
Q

Kubicek et al. 2016. Outcomes and prognostic factors associated with canine sinonasal tumors treated with curative intent cone-based stereotactic radiosurgery

Canine patients treated with SRS for sinonasal tumors

Sarcoma (9), carcinoma (40), OSA (7), round cell (1)

Late effects occured in 23 cases - grades I-III

MST?

MST for CA, SA, OSA

A
  1. 5 months
  2. 4, 10.7, 3.1 months
19
Q

Kuhlman et al. 2016. Use of frameless CT-guided stereotactic biopsy system for nasal biopsy in 5 dogs

Malignant neoplasia diagnosed in 3 dogs, inflammation in 1 and hamartoma in 1 dogs

Biopsy specimens were safely collected

A
20
Q

Lux et al. 2017. Prospective comparison of tumor staging using CT versus MRI findings in dogs with nasal neoplasia: a pilot study

Evaluation of bone involvement showed __ level of agreesment between CT and MRI?

Estimation of tumor volume was higher on?

Disagreement between CT and MRI was noted with?

Tumor stage?

MRI resulted in larger biodimensional measurements and tumor volume estimates along with higher liklihood of identifying meningeal enhacement when compared to CT

A

High

MRI than CT

Meningeal enhancement

Higher in 1 on MRI while other 5 agreed

21
Q

Jafry et al. 2017. Proposed expansion margins for planning organ at risk volume for lenses during radiation therapy of the nasal cavity in dogs and cats

Optimal expansion from the lens voulme of __ in cats and __ in dogs may be necessary in generating PRV (planning organ at risk volume) expansion

A

2 mm and 3mm

22
Q

Gasymova et al. 2017. Retrospective clinical study on outcome in cats with nasal planum SCC treated with accelerated RT

Response to treatment?

Median DFI?

1- and 2-year DFI

What variable influence DFI

Median OS

1- and 2-year OS

What variable influence OS

A

Complete response in all cats

916 days

70% and 60%

Tumor volume - larger tumors having 5.4x risk of recurrence

902 days

80% and 60%

Tumor volume - larger tumors having 6.3x greater risk of dying than smaller ones

23
Q

Gieger et al. 2017. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumors: 29 cases (2013-2016)

Clinical signs after treatment?

19 dogs had CT 3-4 months post-SRT, tumor response?

Acute tocxicity?

Late toxicity?

Median PFS? progression free at 1 and 2 year?

Median OS? at 1- and 2-year?

A

Improved in all cases

PR or CR

Minimal

oronasal or nasocutaneous fistulas (3) and fungal rhinitis (2)

354 days, 49% and 39%

586 days (19.5 months), 69% and 22%

24
Q

Ojeda et al. 2018. CT imaging in 4 dogs with primary nasal canine TVT and differing cellular phenotye

Plamacytoid phenotype identified in cases with most important damage to nasal cavity - did not affect response to chemotherapy

A
25
Q

Woodruff et al. 2018. Canine intranasal tumors treated with alternating carboplatin and doxorubicin in conjunction with oral piroxicam: 29 cases

Overall MST?

MST adenocarcinoma or carcinoma?

MST transitional cell carcinoma?

SCC, anaplastic carcinoma, undifferentiated carcinoma?

MST sarcoma?

A

234 days (8 months)

280 days (9 months)

163 days (5.4 months)

59 days (2 months)

448 days (15 months)

Potential benefit for adenocarcinoma, carcinoma, and sarcoma

26
Q

Skinner et al. 2018. Diagnostic accuracy of contrast-enhanced CT for assessment of mandibular and medial retrophraryngeal LN metastasis for dogs with oral and nasal cancer

Agreement was perfect for?

Sensitivity of CT for mandibular and medial retrophraryngeal?

Specificity of CT for mandibular and medial retrophraryngeal?

Accuracy of CT for mandibular and medial retrophraryngeal?

A

margination, attenuation and enhancement, strong for mandibular LN mets, and weak for medial retropharngeal mets

12.5% and 10%

91% and 97%

67.5% and 76.3%

Given the low sensitivity of CT cannie be relied on alone for metastasis

27
Q

Hocker et al. 2017. Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma

16 nasal carcinomaVEGFR2 expression?

PDGFR-a

PDGFR-b

Protein expression for c-kit?

EGFR?

Phosphorylation of VEGFR2, PDGFR-a, PDGFR-b?

Phosphorylation of EGFR1?

Clinical benefit of toceranib occurs through alernative unidentified RTK pathway

A

Protein expressed in all carcinomas

15/16

3/16

4/16

14/16

None observed

10/16 samples and 3/5 normal samples

28
Q

Ishigaki et al. 2018. Endoscopic photocynamic therapy using talaporfin sodium for recurrent intranasal carcinomas after RT on 3 dogs

PDT induced complete remission and prolonged survival time in all cases

A